SOX11 is a key epigenetic regulator in the adrenergic MYCN amplified neuroblastoma
- Author
- Amber Louwagie (UGent) , Bieke Decaesteker (UGent) , Carolina de Carvalho Nunes (UGent) , Geertrui Denecker (UGent) , Volodimir Olexiouk (UGent) , Karen Verboom, Moritz Gartlgruber, Wouter Van Loocke (UGent) , Elena Afanasyeva, Pauline Depuydt, Fanny De Vloed (UGent) , Ellen Sanders (UGent) , Liselot Mus (UGent) , Carl Herrmann, Siebe Loontiens (UGent) , Lucia Lorenzi, Carl Herrmann, Jo Van Dorpe (UGent) , David Creytens (UGent) , Frank Westerman, Rogier Versteeg, Björn Menten (UGent) , Nadine Van Roy (UGent) , Kaat Durinck (UGent) , Suzanne Vanhauwaert (UGent) , Christophe Van Neste (UGent) , Sara Ek, Johan Van Nes, Jan Koster, Katleen De Preter (UGent) and Franki Speleman (UGent)
- Organization
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-8630817
- MLA
- Louwagie, Amber, et al. “SOX11 Is a Key Epigenetic Regulator in the Adrenergic MYCN Amplified Neuroblastoma.” OncoPoint, 7th Research Seminar, Abstracts, 2019.
- APA
- Louwagie, A., Decaesteker, B., de Carvalho Nunes, C., Denecker, G., Olexiouk, V., Verboom, K., … Speleman, F. (2019). SOX11 is a key epigenetic regulator in the adrenergic MYCN amplified neuroblastoma. OncoPoint, 7th Research Seminar, Abstracts. Presented at the 7th OncoPoint research seminar, Ghent, Belgium.
- Chicago author-date
- Louwagie, Amber, Bieke Decaesteker, Carolina de Carvalho Nunes, Geertrui Denecker, Volodimir Olexiouk, Karen Verboom, Moritz Gartlgruber, et al. 2019. “SOX11 Is a Key Epigenetic Regulator in the Adrenergic MYCN Amplified Neuroblastoma.” In OncoPoint, 7th Research Seminar, Abstracts.
- Chicago author-date (all authors)
- Louwagie, Amber, Bieke Decaesteker, Carolina de Carvalho Nunes, Geertrui Denecker, Volodimir Olexiouk, Karen Verboom, Moritz Gartlgruber, Wouter Van Loocke, Elena Afanasyeva, Pauline Depuydt, Fanny De Vloed, Ellen Sanders, Liselot Mus, Carl Herrmann, Siebe Loontiens, Lucia Lorenzi, Carl Herrmann, Jo Van Dorpe, David Creytens, Frank Westerman, Rogier Versteeg, Björn Menten, Nadine Van Roy, Kaat Durinck, Suzanne Vanhauwaert, Christophe Van Neste, Sara Ek, Johan Van Nes, Jan Koster, Katleen De Preter, and Franki Speleman. 2019. “SOX11 Is a Key Epigenetic Regulator in the Adrenergic MYCN Amplified Neuroblastoma.” In OncoPoint, 7th Research Seminar, Abstracts.
- Vancouver
- 1.Louwagie A, Decaesteker B, de Carvalho Nunes C, Denecker G, Olexiouk V, Verboom K, et al. SOX11 is a key epigenetic regulator in the adrenergic MYCN amplified neuroblastoma. In: OncoPoint, 7th Research seminar, Abstracts. 2019.
- IEEE
- [1]A. Louwagie et al., “SOX11 is a key epigenetic regulator in the adrenergic MYCN amplified neuroblastoma,” in OncoPoint, 7th Research seminar, Abstracts, Ghent, Belgium, 2019.
@inproceedings{8630817,
author = {{Louwagie, Amber and Decaesteker, Bieke and de Carvalho Nunes, Carolina and Denecker, Geertrui and Olexiouk, Volodimir and Verboom, Karen and Gartlgruber, Moritz and Van Loocke, Wouter and Afanasyeva, Elena and Depuydt, Pauline and De Vloed, Fanny and Sanders, Ellen and Mus, Liselot and Herrmann, Carl and Loontiens, Siebe and Lorenzi, Lucia and Herrmann, Carl and Van Dorpe, Jo and Creytens, David and Westerman, Frank and Versteeg, Rogier and Menten, Björn and Van Roy, Nadine and Durinck, Kaat and Vanhauwaert, Suzanne and Van Neste, Christophe and Ek, Sara and Van Nes, Johan and Koster, Jan and De Preter, Katleen and Speleman, Franki}},
booktitle = {{OncoPoint, 7th Research seminar, Abstracts}},
language = {{eng}},
location = {{Ghent, Belgium}},
title = {{SOX11 is a key epigenetic regulator in the adrenergic MYCN amplified neuroblastoma}},
year = {{2019}},
}